UroSens' Grant

UroSens raised a round of funding on November 11, 2011. Investors include Innovate UK.

UroSens is developing diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. The Company has a worldwide exclusive license, from Cancer Research Technology, for …

Articles about UroSens' Grant: